Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 142 No. 2930 (2012)

Silicone breast implant materials

  • A. U. Daniels
DOI
https://doi.org/10.4414/smw.2012.13614
Cite this as:
Swiss Med Wkly. 2012;142:w13614
Published
15.07.2012

Summary

This opinion article has been written on request because of the recent public controversy over silicone breast implants produced by a now-defunct company, Poly Implant Prosthese (PIP) in France. More than 300,000 PIP devices have been implanted. The purposes of my article are to (1.) provide a general overview of silicone breast implant materials, (2.) to describe the general safety of these materials as reported to date, and (3.) to summarise current publicly available information about these aspects of the PIP prostheses. The materials covered are the silicone rubber from which the implant shells are made and the silicone gel used to fill the shell. The materials safety issues are biocompatibility (especially of the gel) and biodurability of the shell. The literature reviewed indicates that biocompatibility is not an issue with other current generation implants. However, biodurability is. A rough estimate of implant shell rupture rate is ~10+% at 10 years. Information is still emerging about the PIP implants. Initial regulatory disclosures suggest the PIP implants may have both biocompatibility and biodurability problems. They also suggest that PIP implants may have been produced using silicone materials not certified as medical grade. Governmental health and regulatory agencies are just now in the process of deciding what actions should be taken to protect patients.

References

  1. Colas A, Curtis J. Ch. 2.3 Silicone biomaterials: history and chemistry. In: Ratner B, Hoffman A, Schoen F, Lemons J (editors). Biomaterials Science: An Introduction to Materials in Medicine. 2nd Edition. New York: Elsevier; 2004. p. 80–6.
  2. Colas A, Curtis J. Ch. 7.19 Medical applications of silicones. In: Ratner B, Hoffman A, Schoen F, Lemons J (editors). Biomaterials Science: An Introduction to Materials in Medicine. 2nd Edition. New York: Elsevier; 2004. p. 697–707.
  3. (Unknown authors). Silicone, in Wikipedia the Free Encyclopedia, Wikimedia Foundation, San Francisco CA USA. (http://en.wikipedia.org/wiki/Silicone – vers. 2012.01.16).
  4. (Unknown authors). Polydimethylsiloxane, in Wikipedia the Free Encyclopedia, Wikimedia Foundation, San Francisco CA USA. (http://en.wikipedia.org/wiki/Polydimethylsiloxane – vers. 2012.01.23).
  5. (Unknown authors). Breast_implant, in Wikipedia the Free Encyclopedia, Wikimedia Foundation, San Francisco CA USA. (http://en.wikipedia.org/wiki/Breast_implant – vers. 2012.01.16)
  6. (Unknown authors). Gel, in Wikipedia the Free Encyclopedia, Wikimedia Foundation, San Francisco CA USA. (http://en.wikipedia.org/wiki/Gel - vers. 2012.01.23)
  7. (Unknown authors). Crosslinking, in Wikipedia the Free Encyclopedia, Wikimedia Foundation, San Francisco CA USA. (http://en.wikipedia.org/wiki/Crosslinking – vers. 2012.01.23).
  8. Lykissa ED, Kala SV, Hurley JB, Lebovitz RM. Release of low molecular weight silicones and platinum from silicone breast implants. Anal Chem. 1997;69:4912–6.
  9. Flassbeck D, Pfleiderer B, Klemens P, Heumann KG, Eltze E, Hirner AV. Determination of siloxanes, silicon, and platinum in tissues of women with silicone gel-filled implants. Anal Bioanal Chem. 2003;375:356–62.
  10. US Government Depts. of Health & Human Services and Labor. Occupational Health Guideline for soluble platinum salts (as platinum). 1978.
  11. Banks HT, Potter LK, Zhang Y. Stress-strain laws for carbon black and silicon filled elastomers. Proc. 36th IEEE Conf. on Dec. and Control;1997.
  12. (Unknown authors). Silicone rubber, in Wikipedia the Free Encyclopedia, Wikimedia Foundation, San Francisco CA USA. (http://en.wikipedia.org/wiki/Silicone_rubber – vers. 2012.01.23).
  13. Cronin TD, Gerow FJ (1963). Augmentation Mammaplasty: A New “natural feel” prosthesis. Excerpta Medica International Congress Series. 1963;66:41.
  14. Lötters JC, Olthuis W, Veltink PH. Bergveld P. The mechanical properties of the rubber elastic polymer polydimethylsiloxane for sensor applications. J Micromech Microeng. 1997;7:145–7.
  15. McLaughlin JK, Nyrén O, Blot WJ, Yin L, Josefsso, S, Fraumeni JF, et al. Cancer risk among women with cosmetic breast implants: a population-based cohort study in sweden. J Nat Cancer Inst. 1998;90(2):156.
  16. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Breast cancer following augmentation mammoplasty (United States). Cancer Causes Control 2000;11:819.
  17. Mellemkjaer L, Kjøller K, Friis S, McLaughlin JK, Høgsted C, Winther JF, et al. Cancer occurrence after cosmetic breast implantation in Denmark. Int J Cancer. 2000;88:301.
  18. Park AJ, Chetty U, Watson ACH. Silicone breast implants and breast cancer. Breast. 1998;7(1):22.
  19. Deapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles Study. Plast Reconstr Surg. 1997;99(5):1346.
  20. Brinton LA, Malone KE, Coates RJ, Schoenberg JB, Swanson CA, Daling JR, et al. Breast enlargement and reduction: results from a breast cancer case-control study. Plast Reconstr Surg. 1996;97(2):269.
  21. Herdman RC, Fahey TJ. Silicone breast implants and cancer. Cancer Investi 2001;19(8):821.
  22. Hennekens CH, Lee IM, Cook NR, Hebert PR, Karlson EW, LaMotte F, Manson JE, Buring JE. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA. 1996;275(8): 616.
  23. Sánchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicon breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995;332(25):1666.
  24. Gabriel SE, O’Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ 3rd. Risk of connective- tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330(24):1697.
  25. Nyrén O, Yin L, Josefsson S, McLaughlin JK, Blot WJ, Engqvist M, et al. Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. Br Med J. 1998;316(7129):417.
  26. Edworthy SM, Martin L, Barr SG, Birdsell DC, Brant RF, Fritzler MJ. A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol. 1998;25(2): 254.
  27. Kjøller K, Friis S, Mellemkjaer L, McLaughlin JK, Winther JF, Lipworth L, et al. Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Int Med. 2001;161:973.
  28. Black J. Biological performance of materials. New York: Marcel Dekker; 1992.
  29. ISO materials biocompatibility matrix, in assessing biocompatibility: A guide for medical device manufacturers. SGS Life Science Services, Fairfield NJ USA, 22 p. 2007.
  30. Brandon HJ, Jerina KL, Wolf CJ, Young VL. Biodurability of retrieved silicone gel breast implants. Plastic & Reconstructive Surgery. 2003;111(7):2295–306.
  31. Taylor RB, Eldred DE, Kim G, Curtis JM, Brandon HJ, Klykken PC. Assessment of silicone gel breast implant biodurability by NMR and EDS techniques. J Biomedical Materials Res. 2008;85A:684–91.
  32. Brown SL, Middleton MS, Berg WA, Soo MS, Penello G. Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. Am J Radiology. 2000;175:1057–64.
  33. Hölmich LR, Friis S, Fryzek JP, Vejborg IM, Carsten C, Sletting S, et al. Incidence of silicone breast implant rupture. Arch. Surgery. 2003;138:801–6.
  34. Heden P, Nava MB, Tetering JPB, Magalon G, Fourie LR, Brenner RJ, et al. Prevalence of rupture in inamed silicone breast implants. Plastic & Reconstructive Surgery 2006;118:303.
  35. (no author named) FDA update on the safety of silicone gel-filled breast implants. 2011. Center for Devices & Radiological Health, U.S. Food & Drug Adminstration.
  36. Neuhann-Lorenz C, Fedeles J, Eisenman-Klein M, Kinney B, Cunningham BL. Eighth IQUAM Consensus Conference Position Statement: Transatlantic innovations, April 2009. Plastic & Reconstructive Surgery 2011;127:1368–75.
  37. (No author named). PIP breast implants – latest from the NHS. 2 February 2012. http://www.nhs.uk/news/.
  38. (No author named). Breast implants with silicone based gel filling from Poly Implant Prothèse company: Update of tests results. 14 April 2011. Medical Devices Evaluation Direction, Vigilance Department. Agence Française de sécurité sanitaire des produits de santé. Republique Française.
  39. (No author named). Xavier Bertrand et Nora Berra, ministres chargés de la Santé, ont reçu les conclusions du rapport sur les prothèses mammaires Poly Implant Prothèse, réalisé par la DGS et l’AFSSAPS. 1 February 2012. http://travail-sante.gouv.fr.
  40. Keough B. Pip breast implants: Interim report of the experts group. 6 January 2012. NHS Medical Directorate, Department of Health, United Kingdom.
  41. (No author named). Defective “PIP” silicone-filled breast implants, Rueckruf_PIP_Silikon-Brustimplantate_(Update_dfe)_2011-12-23.doc, Swissmedic - Hallerstr. 7 - Postfach - CH-3000 Bern.
  42. (No author named). Fuel additive in banned PIP breast implants – report. BBC News Europe. 2 January 2012. http://www.bbc.co.uk/news/world-europe-16384708.
  43. (No author named). Bayer silicones Baysilon® fluids M. No date given. Bayer AG Inorganics Business Group, Silicones Business Unit, Baysilone Marketing Section. 51368 Leverkusen DE.
  44. High Tear Strength Silopren® LSR4600 Series. May 2010. Momentive performance materials, Inc. Columbus OH USA.
  45. (No author named). Bluestar Silicones, Oil 47. No date given. Bluestar Silicones France SAS. Lyon France.